Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease

被引:0
|
作者
Christopher Ma [1 ]
Brennan Walters [1 ]
Richard N Fedorak [1 ]
机构
[1] Division of Gastroenterology,University of Alberta,Edmonton,AL T6G 2X8,Canada
关键词
Varicella zoster virus; Meningitis; Crohn’s disease; Adalimumab; Infliximab; corticosteroids; Antitumor necrosis factor;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
Opportunistic viral infections are a well-recognized complication of anti-tumor necrosis factor (TNF) therapy for inflammatory bowel disease (IBD). Cases of severe or atypical varicella zoster virus infection, both primary and latent reactivation, have been described in association with immunosuppression of Crohn’s disease (CD) patients. However, central nervous system varicella zoster virus infections have been rarely described, and there are no previous reports of varicella zoster virus meningitis associated with anti-TNF therapy among the CD population. Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab. The reactivation presented as debilitating varicella zoster virus meningitis, which was not completely resolved despite aggressive antiviral therapy with prolonged intravenous acyclovir and subsequent oral valacyclovir. This is the first reported case of opportunistic central nervous system varicella zoster infection complicating anti-TNF therapy in the CD population. This paper also reviews the literature on varicella zoster virus infections of immunosuppressed IBD patients and the importance of vaccination prior to initiation of anti-TNF therapy.
引用
收藏
页码:3347 / 3351
页数:5
相关论文
共 50 条
  • [1] Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease
    Ma, Christopher
    Walters, Brennan
    Fedorak, Richard N.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (21) : 3347 - 3351
  • [2] Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease
    Thomas, CW
    Weinshenker, BG
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (01) : 28 - 31
  • [3] Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen M.
    Chen, Lang
    Xie, Fenglong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1293 - +
  • [4] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [5] Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease
    Umeno, Junji
    Matsumoto, Takayuki
    Jo, Yukihiko
    Ichikawa, Miki
    Urabe, Kazunori
    Lida, Mitsuo
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (09) : 1188 - 1189
  • [6] Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease
    Kane, Sunanda V.
    Jaganathan, Srihari
    Bedenbaugh, Angela V.
    Palmer, Liisa
    Schwartz, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (09) : 1821 - 1826
  • [7] A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease
    Papamichael, Konstantinos
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 493 - 501
  • [8] Anti-Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery
    Herfarth, Hans H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1503 - 1506
  • [9] A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn's Disease
    Nie, Kai
    Zhang, Chao
    Deng, Minzi
    Luo, Weiwei
    Ma, Kejia
    Xu, Jiahao
    Wu, Xing
    Yang, Yuanyuan
    Wang, Xiaoyan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
    Ye, Byong Duk
    INTESTINAL RESEARCH, 2014, 12 (04) : 263 - 265